Related references
Note: Only part of the references are listed.Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis
Siavash Jafari et al.
CUAJ-Canadian Urological Association Journal (2016)
Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis
Salaheddin M. Mahmud et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital Automated Database
Cristina Varas-Lorenzo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Effects of Non-Selective Non-Steroidal Anti-Inflammatory Drugs on the Aggressiveness of Prostate Cancer
David C. Stock et al.
PROSTATE (2008)
A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence
Eric J. Jacobs et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force
Alaa Rostom et al.
ANNALS OF INTERNAL MEDICINE (2007)
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors
Sabine Groesch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor
Bhagavathi A. Narayanan et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population
SM Mahmud et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2006)
Aspirin and the risk of prostate cancer
C Bosetti et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2006)
Multiple-bias modelling for analysis of observational data
S Greenland
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2005)
COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer
AL Sabichi et al.
SEMINARS IN ONCOLOGY (2004)
Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis
S Mahmud et al.
BRITISH JOURNAL OF CANCER (2004)
Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer
L Perron et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis
DA Corley et al.
GASTROENTEROLOGY (2003)
Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk
J Irani et al.
JOURNAL OF UROLOGY (2002)
Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US
LA Habel et al.
CANCER CAUSES & CONTROL (2002)
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
MJ Thun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
The role of cyclooxygenase-2 in prostate cancer
A Kirschenbaum et al.
UROLOGY (2001)
Breast cancer and NSAID use: a meta-analysis
SA Khuder et al.
BRITISH JOURNAL OF CANCER (2001)
The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
AL Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Prostate cancer in Saskatchewan Canada, before and during the PSA era
D Skarsgard et al.
CANCER CAUSES & CONTROL (2000)
Share Paper
